These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15556143)

  • 1. Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline.
    Cornet S; Spinnewyn B; Delaflotte S; Charnet C; Roubert V; Favre C; Hider H; Chabrier PE; Auguet M
    Eur J Pharmacol; 2004 Nov; 505(1-3):111-9. PubMed ID: 15556143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.
    Du Y; Ma Z; Lin S; Dodel RC; Gao F; Bales KR; Triarhou LC; Chernet E; Perry KW; Nelson DL; Luecke S; Phebus LA; Bymaster FP; Paul SM
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14669-74. PubMed ID: 11724929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions.
    Fernandez-Gomez FJ; Galindo MF; Gomez-Lazaro M; González-García C; Ceña V; Aguirre N; Jordán J
    Neuroscience; 2005; 133(4):959-67. PubMed ID: 15964487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel free radical spin traps protect against malonate and MPTP neurotoxicity.
    Matthews RT; Klivenyi P; Mueller G; Yang L; Wermer M; Thomas CE; Beal MF
    Exp Neurol; 1999 May; 157(1):120-6. PubMed ID: 10222114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K; Miller DB; O'Callaghan JP
    J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline.
    Månsson R; Hansson MJ; Morota S; Uchino H; Ekdahl CT; Elmér E
    Neurobiol Dis; 2007 Jan; 25(1):198-205. PubMed ID: 17067803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minocycline enhances MPTP toxicity to dopaminergic neurons.
    Yang L; Sugama S; Chirichigno JW; Gregorio J; Lorenzl S; Shin DH; Browne SE; Shimizu Y; Joh TH; Beal MF; Albers DS
    J Neurosci Res; 2003 Oct; 74(2):278-85. PubMed ID: 14515357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minocycline fails to protect cerebellar granular cell cultures against malonate-induced cell death.
    Fernandez-Gomez FJ; Gomez-Lazaro M; Pastor D; Calvo S; Aguirre N; Galindo MF; Jordán J
    Neurobiol Dis; 2005 Nov; 20(2):384-91. PubMed ID: 16242643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
    Zhai A; Zhu X; Wang X; Chen R; Wang H
    Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
    Castagnoli K; Palmer S; Castagnoli N
    Neurobiology (Bp); 1999; 7(2):135-49. PubMed ID: 10591048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of the andrographolide analogue AL-1 in the MPP⁺/MPTP-induced Parkinson's disease model in vitro and in mice.
    Zhang Z; Lai D; Wang L; Yu P; Zhu L; Guo B; Xu L; Zhou L; Sun Y; Lee SM; Wang Y
    Pharmacol Biochem Behav; 2014 Jul; 122():191-202. PubMed ID: 24726706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
    Kawasaki T; Ago Y; Kitao T; Nashida T; Takagi A; Takuma K; Matsuda T
    Neuropharmacology; 2008 Oct; 55(5):654-60. PubMed ID: 18573265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.
    Koga K; Mori A; Ohashi S; Kurihara N; Kitagawa H; Ishikawa M; Mitsumoto Y; Nakai M
    Eur J Neurosci; 2006 Feb; 23(4):1077-81. PubMed ID: 16519673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.
    Ookubo M; Yokoyama H; Takagi S; Kato H; Araki T
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):87-93. PubMed ID: 18755240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated neuroprotection in an MPTP-induced model of Parkinson's disease.
    Kim HG; Park G; Piao Y; Kang MS; Pak YK; Hong SP; Oh MS
    Food Chem Toxicol; 2014 Mar; 65():293-300. PubMed ID: 24389454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-allylcysteine reduces the MPTP-induced striatal cell damage via inhibition of pro-inflammatory cytokine tumor necrosis factor-α and inducible nitric oxide synthase expressions in mice.
    García E; Villeda-Hernández J; Pedraza-Chaverrí J; Maldonado PD; Santamaría A
    Phytomedicine; 2010 Dec; 18(1):65-73. PubMed ID: 20576415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax.
    Youdim MB; Arraf Z
    Neuropharmacology; 2004 Jun; 46(8):1130-40. PubMed ID: 15111020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.